Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
RNA polymerase | R-HSA-73864 | map03020 | chloropyrazine | 33478 | drug-path |
Hematopoietic cell lineage | R-HSA-173752 | map04640 | monocrotaline | 9415 | drug-path |
Amyotrophic lateral sclerosis (ALS) | Q8NDH6-2 | 0 | monocrotaline | 9415 | drug-path |
TGF-beta signaling pathway | R-HSA-168638 | map04350 | monocrotaline | 9415 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | harmine | 6178111 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | harmine | 6178111 | drug-path |
p53 signaling pathway | R-HSA-168638 | map04115 | harmine | 6178111 | drug-path |
Allograft rejection | R-HSA-9679028 | map05330 | harmine | 6178111 | drug-path |
Graft-versus-host disease | R-HSA-1643685 | map05332 | harmine | 6178111 | drug-path |
Natural killer cell mediated cytotoxicity | R-HSA-5218921 | map04650 | harmine | 6178111 | drug-path |
Hematopoietic cell lineage | R-HSA-173752 | map04640 | harmine | 6178111 | drug-path |
PPAR signaling pathway | R-HSA-168638 | map03320 | harmine | 6178111 | drug-path |
Alzheimer's disease | R-HSA-1643685 | 0 | harmine | 6178111 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | harmine | 6178111 | drug-path |
Taste transduction | R-HSA-162582 | map04742 | harmine | 6178111 | drug-path |
Autoimmune thyroid disease | R-HSA-1643685 | map05320 | harmine | 6178111 | drug-path |
Antigen processing and presentation | R-HSA-1236975 | map04612 | harmine | 6178111 | drug-path |
Leukocyte transendothelial migration | R-HSA-8950732 | map04670 | harmine | 6178111 | drug-path |
Huntington's disease | R-HSA-1643685 | 0 | harmine | 6178111 | drug-path |
Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | harmine | 6178111 | drug-path |